Literature DB >> 19615842

Isolation and structure determination of oxidative degradation products of atorvastatin.

Matjaz Kracun1, Andrej Kocijan, Andrej Bastarda, Rok Grahek, Janez Plavec, Darko Kocjan.   

Abstract

Methods were developed for the preparation and isolation of four oxidative degradation products of atorvastatin. ATV-FX1 was prepared in the alkaline acetonitrile solution of atorvastatin with the addition of hydrogen peroxide. The exposition of aqueous acetonitrile solution of atorvastatin to sunlight for several hours followed by the alkalization of the solution with potassium hydroxide to pH 8-9 gave ATV-FXA. By the acidification of the solution with phosphoric acid to pH 3 ATV-FXA1 and FXA2 were prepared. The isolation of oxidative degradation products was carried out on a reversed-phase chromatographic column Luna prep C18(2) 10 microm applying several separation steps. The liquid chromatography coupled with a mass spectrometer (LC-MS), high resolution MS (HR-MS), 1D and 2D NMR spectroscopy methods were applied for the structure elucidation. All degradants are due to the oxidation of the pyrrole ring. The most probable reaction mechanism is intermediate endoperoxide formation with subsequent rearrangement and nucleophilic attack by the 5-hydroxy group of the heptanoic fragment. ATV-FX1 is 4-[1b-(4-Fluoro-phenyl)-6-hydroxy-6-isopropyl-1a-phenyl-6a-phenylcarbamoyl-hexahydro-1,2-dioxa-5a-aza-cyclopropa[a]inden-3-yl]-3-(R)-hydroxy-butyric acid and has a molecular mass increased by two oxygen atoms with regard to atorvastatin. ATV-FXA is the regioisomeric compound, 4-[6-(4-Fluoro-phenyl)-6-hydroxy-1b-isopropyl-6a-phenyl-1a-phenylcarbamoyl-hexahydro-1,2-dioxa-5a-aza-cyclopropa[a]inden-3-yl]-3-(R)-hydroxy-butyric acid. Its descendants ATV-FXA1 and FXA2 appeared without the atorvastatin heptanoic fragment and are 3-(4-Fluoro-benzoyl)-2-isobutyryl-3-phenyl-oxirane-2-carboxylic acid phenylamide and 4-(4-Fluoro-phenyl)-2,4-dihydroxy-2-isopropyl-5-phenyl-3,6-dioxa-bicyclo[3.1.0]hexane-1-carboxylic acid phenylamide, respectively. Quantitative NMR spectroscopy was employed for the assay determination of isolated oxidative degradation products. The results obtained were used for the determination of the UV response factors relative to atorvastatin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615842     DOI: 10.1016/j.jpba.2009.06.008

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation.

Authors:  Furquan Nazimuddin Khan; Mohamed Hassan G Dehghan
Journal:  AAPS PharmSciTech       Date:  2011-08-31       Impact factor: 3.246

Review 2.  Oxidation of Drugs during Drug Product Development: Problems and Solutions.

Authors:  Alen Gabrič; Žiga Hodnik; Stane Pajk
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321

3.  Spectroscopic studies on photodegradation of atorvastatin calcium.

Authors:  Madalina Oprica; Miruna Iota; Monica Daescu; Szilard N Fejer; Catalin Negrila; Mihaela Baibarac
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.